SCHEMBL6060698

SCHEMBL6060698

CC(C)(C)c1cc(COP(=O)(OCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)OCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 3/20 0.55
GAA P10253 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 7/20 0.49
TSHR P16473 3/20 0.49
MAPK1 P28482 3/20 0.49
LMNA P02545 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
BLM P54132 2/20 0.49
ATM Q13315 2/20 0.49
HIF1A Q16665 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
MAPT P10636 2/20 0.49
USP2 O75604 1/20 0.49
CYP2D6 P10635 1/20 0.49
NR1I2 O75469 1/20 0.48
GMNN O75496 1/20 0.47
GABBR2 O75899 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL134656 0.94 HMGCR (0.61) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL7795970 0.92 HMGCR (0.51) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL27737672 0.88 HMGCR (0.54) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL29270355 0.88 HMGCR (0.54) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL818663 0.88 HMGCR (0.54) HMGCRGAAMEN1KMT2AALDH1A1
Tetrylammonium SCHEMBL27764037 0.87 HMGCR (0.54) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL27737673 0.86 HMGCR (0.52) HMGCRGAAMEN1KMT2AALDH1A1
Magnesium SCHEMBL4347217 0.86 HMGCR (0.52) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL5709912 0.86 HMGCR (0.52) HMGCRGAAMEN1KMT2AALDH1A1
SCHEMBL39203 0.86 HMGCR (0.47) HMGCRGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269805-A Process for preparing polyisocyanate compositions 韩华思路信(株) 2022-04-01 CN claimed
WO-2021040316-A1 METHOD FOR PRODUCING POLYISOCYANATE COMPOSITION 한화솔루션 주식회사 2021-03-04 WO claimed
EP-4733334-A1 METHACRYLIC RESIN AND METHOD FOR PRODUCING SAME, METHACRYLIC RESIN COMPOSITION, AND MOLDED BODY Kuraray Co., Ltd. (JP) 2026-04-29 EP disclosed
EP-4733356-A1 METHACRYLIC RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED BODY Kuraray Co., Ltd. (JP) 2026-04-29 EP disclosed
EP-4613784-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2025-09-10 EP disclosed
EP-4610284-A1 MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT Mitsubishi Chemical Corporation (JP) 2025-09-03 EP disclosed
US-20250250221-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250370-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250223-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250376-A1 MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250236582-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING (METH)ACRYLIC POLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 2025-07-24 US disclosed
US-20020182520-A1 Electrophotography system; characteristic controlling member which is provided at a side of the substrate which is opposite to the side where the image is formed. FUJI XEROX CO., LTD. (JP) 2002-12-05 US disclosed
EP-1245623-A1 Rubber compositions and their uses Mitsui Chemicals, Inc. (JP) 2002-10-02 EP disclosed
CN-1333788-A In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes GOODRICH CO B F (US) 2002-01-30 CN disclosed
EP-0761756-B1 STABILIZER FOR HALOGEN-CONTAINING RESINS AND PROCESS FOR THE PREPARATION THEREOF, HALOGEN-CONTAINING RESIN COMPOSITION, AND COMPOSITE HYDROXIDE SALT FUJI CHEM IND CO LTD (JP) 1999-10-27 EP disclosed
EP-0778241-B1 NOVEL COMPOSITE HYDROXIDE/CONDENSED SILICATES, PROCESS FOR THE PRODUCTION THEREOF, INFRARED ABSORBER, AND AGRICULTURAL FILM FUJI CHEM IND CO LTD (JP) 1999-05-12 EP disclosed
US-5840792-A STABILIZER FOR HALOGEN-CONTAINING RESIN FUJI CHEMICAL INDUSTRY CO., LTD. (JP) 1998-11-24 US disclosed
US-5767179-A INFRARED ABSORBERS FUJI CHEMICAL INDUSTRY CO., LTD. (JP) 1998-06-16 US disclosed
EP-0778241-A1 NOVEL COMPOSITE HYDROXIDE/CONDENSED SILICATES, PROCESS FOR THE PRODUCTION THEREOF, INFRARED ABSORBER, AND AGRICULTURAL FILM FUJI CHEMICAL INDUSTRY CO., LTD. (JP) 1997-06-11 EP disclosed
EP-0761756-A1 STABILIZER FOR HALOGEN-CONTAINING RESINS AND PROCESS FOR THE PREPARATION THEREOF, HALOGEN-CONTAINING RESIN COMPOSITION, AND COMPOSITE HYDROXIDE SALT FUJI CHEMICAL INDUSTRY CO., LTD. (JP) 1997-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250221-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME ADCY6, ADCY5, AMD1 HMGCR 743/4885GAA 2219/4885MEN1 387/4885
US-20250236582-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING (METH)ACRYLIC POLYMER MCCC2, ASS1, MMAB HMGCR 239/4885GAA 3074/4885MEN1 231/4885
US-20250250370-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER MMAB, MAT2B, MEP1B HMGCR 974/4885GAA 2797/4885MEN1 454/4885
US-20250250223-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME MMAB, ADCY8, MAT1A HMGCR 428/4885GAA 1744/4885MEN1 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.